original ) (raw )Identification and characterization of a monocyte-derived neutrophil- …
Niraj Mishra
Journal of Clinical …
View PDFchevron_right
Identification and characterization of monocyte subpopulations from patients with bronchial asthma
Vishva Dixit
Journal of Allergy and Clinical Immunology, 1995
View PDFchevron_right
Fibrinolytic activity of a novel serine protease from the hemolymph of a polychaeta, Periserrula leucophryna
Jang Choi
2010
View PDFchevron_right
Purification and characterization of a fibrinogenase from Vipera lebetina (desert adder) venom
zakaria benlasfar , Habib Karoui
Toxicon, 1991
View PDFchevron_right
One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity
Lars Skriver
The Journal of biological chemistry, 1988
View PDFchevron_right
Purification and characterization of a serine protease (CPM-2) with fibrinolytic activity from the dung beetles
Helena Nevalainen
Archives of Pharmacal Research, 2005
View PDFchevron_right
Mechanisms of plasminogen activation
V. Ellis
Journal of Internal Medicine, 1994
View PDFchevron_right
Thrombin: Active-Site Topography
Lawrence Berliner , Jens Birktoft
Annals of the New York Academy of Sciences, 1986
View PDFchevron_right
Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3)
Marc De Maeyer
European journal of biochemistry / FEBS, 2001
View PDFchevron_right
A novel trypsin Kazal-type inhibitor from Aedes aegypti with thrombin coagulant inhibitory activity
Margareth Capurro
Biochimie, 2010
View PDFchevron_right
Biochemical and pharmacological properties of a new thrombin-like serine protease (Russelobin) from the venom of Russell's Viper (Daboia russelii russelii) and assessment of its therapeutic potential
Stephen Mackessy
Biochimica et Biophysica Acta
View PDFchevron_right
Elastase released from human granulocytes stimulated with N-formyl-chemotactic peptide prevents activation of tumor cell prourokinase (pro-uPA)
D. Gulba
FEBS Letters, 1989
View PDFchevron_right
29. Russelobin, a Non-toxic Thrombin-like Serine Protease from the Venom of Russell's Viper (Daboia russelli russelli): Possible Applications in Cardiovascular Drug Development
Stephen Mackessy
Toxicon, 2012
View PDFchevron_right
Biochemical and pharmacological properties of a new thrombin-like serine protease (Russelobin) from the venom of Russell's Viper (Daboia russelii russelii) and assessment of its therapeutic potential - Mukherjee & Mackessy
Stephen Mackessy
Biochimica et Biophysica Acta 1830 (2013) 3476–3488, 2013
View PDFchevron_right
The Protein Z-Dependent Protease Inhibitor Is a Serpin �
George Broze
Biochemistry Usa, 1999
View PDFchevron_right
Biochemical characterization and molecular cloning of a plasminogen activator proteinase (LV-PA) from bushmaster snake venom
Eladio Sanchez
Biochimica et Biophysica Acta (BBA) - General Subjects, 2006
View PDFchevron_right
Proteolytically induced variations in the enzymatic properties of tissue plasminogen activator. Activations, inactivations and reactivations
Bo Norrman
European Journal of Biochemistry, 1986
View PDFchevron_right
Tetranectin binds hepatocyte growth factor and tissue-type plasminogen activator
Sergey Fedosov , Christian Heegaard
European Journal of Biochemistry, 2003
View PDFchevron_right
Hemextin AB Complex – A Snake Venom Anticoagulant Protein Complex That Inhibits Factor VIIa Activity
Y. Banerjee
Pathophysiology of Haemostasis and Thrombosis, 2005
View PDFchevron_right
The cell envelope-bound metalloprotease (camelysin) from Bacillus cereus is a possible pathogenic factor
Angelika Schierhorn
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2001
View PDFchevron_right
Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation
Jan Enghild
Biochemical Journal, 1999
View PDFchevron_right
Isolation and Biochemical Characterization of a Galactoside Binding Lectin from Bauhinia variegata Candida (BvcL) Seeds
Marcelo Mattioli
The Protein Journal, 2007
View PDFchevron_right
Secreted Neutral Metalloproteases of Bacillus anthracis as Candidate Pathogenic Factors
Bryan Millis
Journal of Biological Chemistry, 2006
View PDFchevron_right
Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator
Irina Sazonova
Journal of Thrombosis and Haemostasis, 2009
View PDFchevron_right
Asn12 and Asn278: Critical Residues for In Vitro Biological Activity of Reteplase
Kalyana Sundaram
Advances in Hematology, 2010
View PDFchevron_right
Interaction of a plasminogen activator proteinase, LV-PA with human α2-macroglobulin
Edith Rodríguez
Toxicon, 2006
View PDFchevron_right
The 2.3 angstrom crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator
Doriano Lamba
Journal of Molecular Biology, 1996
View PDFchevron_right
Targeting the autolysis loop of urokinase-type plasminogen activator with conformation-specific monoclonal antibodies
Mingdong Huang
2011
View PDFchevron_right
Trimeresurus stejnegeri Snake Venom Plasminogen Activator. SITE-DIRECTED MUTAGENESIS AND MOLECULAR MODELING
Valerie CHOUMET
Journal of Biological Chemistry, 1997
View PDFchevron_right
Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome
Richard Maunder
Journal of Clinical Investigation, 1989
View PDFchevron_right
Current Status of Activity Assays for Tissue Plasminogen Activator
Shirley Li
Annals of the New York Academy of Sciences, 1984
View PDFchevron_right
Human Complement Factor I Does Not Require Cofactors for Cleavage of Synthetic Substrates
Robert Sim
The Journal of Immunology, 2004
View PDFchevron_right
A Novel Venombin B from Agkistrodon contortrix contortrix : Evidence for Recognition Properties in the Surface around the Primary Specificity Pocket Different from Thrombin †
Angela Amoresano
Biochemistry, 2000
View PDFchevron_right
Characterization of the enzyme activity of human plasma lipoprotein (a) using synthetic peptide substrates
Jari Metso
The Biochemical journal, 1991
View PDFchevron_right
The 2.3 Å Crystal Structure of the Catalytic Domain of Recombinant Two-chain Human Tissue-type Plasminogen Activator
Doriano Lamba
Journal of Molecular Biology, 1996
View PDFchevron_right
Innovative Tests of Plasmatic Hemostasis
Thomas Stief
Laboratory Medicine, 2008
View PDFchevron_right
Enhanced fibrinolysis by proteolysed coagulation factor Xa
Kimberley Talbot , S. Meixner , T. Smith
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
View PDFchevron_right
Triapsin, an unusual activatable serine protease from the saliva of the hematophagous vector of Chagas' disease Triatoma infestans (Hemiptera: Reduviidae)
Rogerio Amino
Insect Biochemistry and Molecular Biology, 2001
View PDFchevron_right
A Refined Kinetic Analysis of Plasminogen Activation by Recombinant Bovine Tissue-Type Plasminogen Activator Indicates Two Interconvertible Activator Forms
Peter Ravn
Biochemistry, 1998
View PDFchevron_right
Regulation of Nonproteolytic Active Site Formation in Plasminogen †
Irina Sazonova
Biochemistry, 2007
View PDFchevron_right